SCHEMBL29537786

SCHEMBL29537786

O=C1C=C2CC=COC2=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899907 0.65 ALDH1A1 (0.35)
SCHEMBL4254738 0.64
SCHEMBL3189508 0.61
SCHEMBL19873 0.60
SCHEMBL8688750 0.60 CA1 (0.41)
SCHEMBL11724475 0.60
SCHEMBL31432500 0.58
Methane SCHEMBL15227989 0.58
Hydrochloric Acid SCHEMBL30045549 0.58
SCHEMBL30449161 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117756766-A 3-hydroxy-8-fluoro-6H-benzo [ c ] chromen-6-one derivative, and preparation method and application thereof 常州大学 2024-03-26 CN claimed
CN-117603178-A Two anti-inflammatory compounds extracted from herba Alternantherae Alternifolia, and extraction method and application thereof 国药集团同济堂(贵州)制药有限公司 2024-02-27 CN claimed
WO-2022094079-A1 METHODS OF TREATING CYSTIC FIBROSIS THE TRUSTEES OF DARTMOUTH COLLEGE (US) 2022-05-05 WO claimed
EP-4712958-A2 USE OF UROLITHIN DERIVATIVES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Vandria SA (CH) 2026-03-25 EP disclosed
EP-4561556-A2 THERAPEUTIC USES OF UROLITHIN DERIVATIVES Vandria SA (CH) 2025-06-04 EP disclosed
EP-4558509-A1 CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY Floratek Pharma SA (CH) 2025-05-28 EP disclosed
CN-119947717-A Therapeutic use of urolithin derivatives 范徳利亚股份公司 2025-05-06 CN disclosed
WO-2025078652-A1 USE OF A UROLITHIN TO PREVENT/SLOW DOWN HAIR GETTING FINER L'OREAL (FR) 2025-04-17 WO disclosed
WO-2025078619-A1 COSMETIC USE OF ISO-UROLITHIN A ON SENSITIVE SKIN L'OREAL (FR) 2025-04-17 WO disclosed
WO-2025051102-A1 DEUTERATED TETRACYCLIC DERIVATIVE AND USE THEREOF 浙江我武翼方药业有限公司 2025-03-13 WO disclosed
CN-119591611-A Deuterated tetracyclic derivative and application thereof 浙江我武翼方药业有限公司 2025-03-11 CN disclosed
CN-117756766-A 3-hydroxy-8-fluoro-6H-benzo [ c ] chromen-6-one derivative, and preparation method and application thereof 常州大学 2024-03-26 CN disclosed
CN-117756766-A 3-hydroxy-8-fluoro-6H-benzo [ c ] chromen-6-one derivative, and preparation method and application thereof 常州大学 2024-03-26 CN disclosed
CN-117603178-A Two anti-inflammatory compounds extracted from herba Alternantherae Alternifolia, and extraction method and application thereof 国药集团同济堂(贵州)制药有限公司 2024-02-27 CN disclosed
WO-2024025953-A2 THERAPEUTIC USES OF UROLITHIN DERIVATIVES VANDRIA SA (CH) 2024-02-01 WO disclosed
WO-2024018017-A1 CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY Floratek Pharma SA (CH) 2024-01-25 WO disclosed
CN-117015530-A Urolithin derivatives and methods of use thereof 范徳利亚股份公司 2023-11-07 CN disclosed
CN-115969793-A Fructooligosaccharide-fish protein glue modified urolithin A liposome and preparation method thereof 江西师范大学 2023-04-18 CN disclosed
CN-111205301-B Furan [2,3-c ] chromene derivatives and process for preparing the same 安徽师范大学 2023-02-21 CN disclosed
CN-114989127-A Compound separated from gentisic acid and separation method and application thereof 北京先通国际医药科技股份有限公司 2022-09-02 CN disclosed